Literature DB >> 25138998

The opioid system and brain development: effects of methadone on the oligodendrocyte lineage and the early stages of myelination.

Allison A Vestal-Laborde1, Andrew C Eschenroeder, John W Bigbee, Susan E Robinson, Carmen Sato-Bigbee.   

Abstract

Oligodendrocytes express opioid receptors throughout development, but the role of the opioid system in myelination remains poorly understood. This is a significant problem as opioid use and abuse continue to increase in two particular populations: pregnant addicts (in whom drug effects could target early myelination in the fetus and newborn) and adolescents and young adults (in whom late myelination of 'higher-order' regions takes place). Maintenance treatments for opioid addicts include the long-lasting opioids methadone and buprenorphine. Similar to our previous findings on the effects of buprenorphine, we have now found that early myelination in the developing rat brain is also altered by perinatal exposure to therapeutic doses of methadone. Pups exposed to this drug exhibited elevated brain levels of the 4 major splicing variants of myelin basic protein, myelin proteolipid protein, and myelin-oligodendrocyte glycoprotein. Consistent with the enrichment and function of these proteins in mature myelin, analysis of the corpus callosum in these young animals also indicated an elevated number of axons with already highly compacted myelin sheaths. Moreover, studies in cultured cells showed that methadone exerts direct effects at specific stages of the oligodendrocyte lineage, stimulating the proliferation of progenitor cells while on the other hand accelerating the maturation of the more differentiated but still immature preoligodendrocytes. While the long-term effects of these observations remain unknown, accelerated or increased oligodendrocyte maturation and myelination could both disrupt the complex sequence of synchronized events leading to normal connectivity in the developing brain. Together with our previous observations on the effects of buprenorphine, the present findings further underscore a crucial function of the endogenous opioid system in the control of oligodendrocyte development and the timing of myelination. Interference with these regulatory systems by opioid use or maintenance treatments could disrupt the normal process of brain maturation at critical stages of myelin formation.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25138998      PMCID: PMC4175303          DOI: 10.1159/000365074

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  84 in total

Review 1.  Developmental clustering of ion channels at and near the node of Ranvier.

Authors:  M N Rasband; J S Trimmer
Journal:  Dev Biol       Date:  2001-08-01       Impact factor: 3.582

Review 2.  Major increases in opioid analgesic abuse in the United States: concerns and strategies.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2005-07-14       Impact factor: 4.492

3.  Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord.

Authors:  B C Warf; J Fok-Seang; R H Miller
Journal:  J Neurosci       Date:  1991-08       Impact factor: 6.167

4.  Myelination in rat brain: changes in myelin composition during brain maturation.

Authors:  W T Norton; S E Poduslo
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

5.  Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia.

Authors:  David Kerns; Ghe S Vong; Kevin Barley; Stella Dracheva; Pavel Katsel; Patrizia Casaccia; Vahram Haroutunian; William Byne
Journal:  Schizophr Res       Date:  2010-05-23       Impact factor: 4.939

6.  Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors.

Authors:  Harsimran S Saini; Rochelle P Coelho; Sravan K Goparaju; Puneet S Jolly; Michael Maceyka; Sarah Spiegel; Carmen Sato-Bigbee
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

7.  Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny.

Authors:  Susan E Robinson
Journal:  Neurotoxicol Teratol       Date:  2002 Mar-Apr       Impact factor: 3.763

8.  Modeling transformations of neurodevelopmental sequences across mammalian species.

Authors:  Alan D Workman; Christine J Charvet; Barbara Clancy; Richard B Darlington; Barbara L Finlay
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

9.  Different neuroligands and signal transduction pathways stimulate CREB phosphorylation at specific developmental stages along oligodendrocyte differentiation.

Authors:  C Sato-Bigbee; S Pal; A K Chu
Journal:  J Neurochem       Date:  1999-01       Impact factor: 5.372

10.  mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.

Authors:  Veronica A Alvarez; Seksiri Arttamangkul; Vu Dang; Abdallah Salem; Jennifer L Whistler; Mark Von Zastrow; David K Grandy; John T Williams
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more
  40 in total

1.  Placental trophoblast transfer of opioids following exposures to individual or mixtures of opioids in vitro.

Authors:  Ninell P Mortensen; Maria M Caffaro; Rodney W Snyder; Yun L Yueh; Timothy R Fennell
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-15

Review 2.  Effects of opioids on the parental brain in health and disease.

Authors:  James E Swain; S Shaun Ho; Helen Fox; David Garry; Susanne Brummelte
Journal:  Front Neuroendocrinol       Date:  2019-05-22       Impact factor: 8.606

3.  Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.

Authors:  Ludmila N Bakhireva; Bradley D Holbrook; Shikhar Shrestha; Yuridia Leyva; Malia Ashley; Sandra Cano; Jean Lowe; Julia M Stephen; Lawrence Leeman
Journal:  Early Hum Dev       Date:  2018-12-13       Impact factor: 2.079

4.  White Matter Injury and Structural Anomalies in Infants with Prenatal Opioid Exposure.

Authors:  S L Merhar; N A Parikh; A Braimah; B B Poindexter; J Tkach; B Kline-Fath
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-17       Impact factor: 3.825

Review 5.  A review on neuroimaging studies of genetic and environmental influences on early brain development.

Authors:  Wei Gao; Karen Grewen; Rebecca C Knickmeyer; Anqi Qiu; Andrew Salzwedel; Weili Lin; John H Gilmore
Journal:  Neuroimage       Date:  2018-04-16       Impact factor: 6.556

Review 6.  Modeling prenatal opioid exposure in animals: Current findings and future directions.

Authors:  Elizabeth M Byrnes; Fair M Vassoler
Journal:  Front Neuroendocrinol       Date:  2017-09-28       Impact factor: 8.606

7.  Opioids affect the fetal brain: reframing the detoxification debate.

Authors:  Steve N Caritis; Ashok Panigrahy
Journal:  Am J Obstet Gynecol       Date:  2019-07-16       Impact factor: 8.661

8.  Methadone effectively attenuates acute and long-term consequences of neonatal repetitive procedural pain in a rat model.

Authors:  Nynke J van den Hoogen; Thomas J de Geus; Jacob Patijn; Dick Tibboel; Elbert A Joosten
Journal:  Pediatr Res       Date:  2021-01-27       Impact factor: 3.756

9.  Identifying the Neurodevelopmental Differences of Opioid Withdrawal.

Authors:  Nynke J van den Hoogen; Charlie H T Kwok; Tuan Trang
Journal:  Cell Mol Neurobiol       Date:  2021-01-12       Impact factor: 5.046

10.  Pilot study of fetal brain development and morphometry in prenatal opioid exposure and smoking on fetal MRI.

Authors:  Rupa Radhakrishnan; Brandon P Brown; David M Haas; Yong Zang; Christina Sparks; Senthilkumar Sadhasivam
Journal:  J Neuroradiol       Date:  2021-01-05       Impact factor: 3.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.